pregnant patient received Menquadfi with no reported adverse event; Initial information received on 24-Jan-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves an unknown age female patient who received meningococcal A-C-Y-W135 (T CONJ) vaccine [menquadfi] with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported pregnant patient received Menquadfi with no reported adverse event occurred at unknown gestation period. The date of last menstrual period was not reported. The estimated due date was not reported. The patient’s past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unkown previous pregnancy/ies. On an unknown date, the patient received unknown dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine Solution for injection (Unknown strength, lot and expiry date) via unknown route in unknown administration site for Immunization with no adverse event (exposure during pregnancy) (Latency same day). There was no information related to Relevant prenatal testing after exposure. Reportedly, Nurse called on behalf of a physician. They said that the physician administered Menactra to a pregnant patient.informed the nurse that Menactra has been discontinued.The nurse clarified that they meant MENQUADFI instead of Menactra. Information on the batch number could not be requested corresponding to the one at time of event occurrence Additionally, at time of reporting, the outcome of the pregnancy is unknown.